BSEInsider Trading / SASTPledge1d ago
Gujarat Themis Biosyn Ltd
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....
Gujarat Themis Biosyn Ltd has received a revised disclosure from Pharmaceutical Business Group (India) Ltd regarding the creation of an indirect encumbrance over 5,12,40,000 shares of the company held by PBGIL, a promoter group entity, due to a pledge of 25,24,245 shares and a non-disposal undertaking of 21,57,855 shares by Vividhmargi Investments Private Ltd in favor of CTL Trusteeship Ltd.
BSEInsider Trading / SASTPledge1d ago
Gujarat Themis Biosyn Ltd
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Pharmaceutical ....
Gujarat Themis Biosyn Ltd has received a revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation of an indirect encumbrance over 5,12,40,000 shares of the company held by Pharmaceutical Business Group (India) Limited, a promoter group entity, due to a pledge of 25,24,245 shares of PBGIL by Vividhmargi Investments Private Limited in favour of CTL Trusteeship Limited.
BSEInsider Trading / SASTPledge1d ago
Gujarat Themis Biosyn Ltd
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Themis Medicare Ltd
Themis Medicare Ltd has released 16,50,000 shares of Gujarat Themis Biosyn Ltd from pledge, as per SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BSEInsider Trading / SASTPledge1d ago
Gujarat Themis Biosyn Ltd
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Pharmaceutical ....
Gujarat Themis Biosyn Ltd has received revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the release of 25,45,000 equity shares from pledge on 8th July, 2026.